Page 45 - AN-3-3
P. 45

Advanced Neurology                                                                   TMAO and stroke



            13.  Chen YY, Ye ZS, Xia NG, Xu Y. TMAO as a novel predictor   24.  Ma G, Pan B, Chen Y,  et al. Trimethylamine N-oxide
               of major adverse vascular events and recurrence in patients   in atherogenesis: Impairing endothelial self-repair
               with large artery atherosclerotic ischemic stroke. Clin Appl   capacity  and  enhancing  monocyte  adhesion.  Biosci
               Thromb Hemost. 2022;28:10760296221090503.          Rep. 2017;37(2):BSR20160244.
               doi: 10.1177/10760296221090503                     doi: 10.1042/BSR20160244
            14.  Farhangi  MA,  Vajdi  M,  Asghari-Jafarabadi  M. Gut   25.  Sun X, Jiao X, Ma Y, et al. Trimethylamine N-oxide induces
               microbiota-associated metabolite trimethylamine N-Oxide   inflammation  and  endothelial  dysfunction  in  human
               and the risk of stroke: A  systematic review and dose-  umbilical vein endothelial cells via activating ROS-TXNIP-
               response meta-analysis. Nutr J. 2020;19(1):76.     NLRP3 inflammasome.  Biochem  Biophys Res  Commun.
                                                                  2016;481(1-2):63-70.
               doi: 10.1186/s12937-020-00592-2
                                                                  doi: 10.1016/j.bbrc.2016.11.017
            15.  Pluta R, Januszewski S, Czuczwar SJ. The role of gut microbiota
               in an ischemic stroke. Int J Mol Sci. 2021;22(2):915.  26.  Janoudi A, Shamoun FE, Kalavakunta JK, Abela GS.
                                                                  Cholesterol crystal induced arterial inflammation and
               doi: 10.3390/ijms22020915
                                                                  destabilization of atherosclerotic plaque.  Eur Heart J.
            16.  Zhu W, Romano KA, Li L, et al. Gut microbes impact stroke   2016;37(25):1959-1967.
               severity via the trimethylamine N-oxide pathway. Cell Host
               Microbe. 2021;29(7):1199-1208.e5.                  doi: 10.1093/eurheartj/ehv653
                                                               27.  Koay YC, Chen YC, Wali JA,  et  al. Plasma levels of
               doi: 10.1016/j.chom.2021.05.002
                                                                  trimethylamine-N-oxide can be increased with ‘healthy’
            17.  Ding L, Chang M, Guo Y,  et al. Trimethylamine-N-oxide   and ‘unhealthy’ diets and do not correlate with the extent of
               (TMAO)-induced atherosclerosis is associated with bile acid   atherosclerosis but with plaque instability. Cardiovasc Res.
               metabolism. Lipids Health Dis. 2018;17(1):286.     2021;117(2):435-449.
               doi: 10.1186/s12944-018-0939-6                     doi: 10.1093/cvr/cvaa094
            18.  Koeth RA, Wang Z, Levison BS, et al. Intestinal microbiota   28.  Maida CD, Norrito RL, Daidone M, Tuttolomondo A,
               metabolism of L-carnitine, a nutrient in red meat, promotes   Pinto A. Neuroinflammatory mechanisms in ischemic
               atherosclerosis. Nat Med. 2013;19(5):576-585.      stroke: Focus on cardioembolic stroke, background, and
               doi: 10.1038/nm.3145                               therapeutic approaches. Int J Mol Sci. 2020;21(18):6454.
                                                                  doi: 10.3390/ijms21186454
            19.  Luqman A, Hassan A, Ullah M,  et al. Role of the
               intestinal microbiome and its therapeutic intervention in   29.  Nam HS. Gut microbiota and ischemic stroke: The role of
               cardiovascular disorder. Front Immunol. 2024;15:1321395.  trimethylamine N-oxide. J Stroke. 2019;21(2):151-159.
               doi: 10.3389/fimmu.2024.1321395                    doi: 10.5853/jos.2019.00472
            20.  Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism   30.  Janeiro MH, Solas M, Orbe J, et al. Trimethylamine N-oxide
               of phosphatidylcholine promotes cardiovascular disease.   as a mediator linking peripheral to central inflammation: An
               Nature. 2011;472(7341):57-63.                      in vitro study. Int J Mol Sci. 2023;24(24):17557.
               doi: 10.1038/nature09922                           doi: 10.3390/ijms242417557
            21.  Vourakis  M, Mayer  G, Rousseau G.  The role  of  gut   31.  Seldin MM, Meng Y, Qi H, et al. Trimethylamine N-oxide
               microbiota on cholesterol metabolism in atherosclerosis. Int   promotes vascular inflammation through signaling of
               J Mol Sci. 2021;22(15):8074.                       mitogen-activated  protein  kinase  and  nuclear  factor-κB.
               doi: 10.3390/ijms22158074                          J Am Heart Assoc. 2016;5(2):e002767.
                                                                  doi: 10.1161/JAHA.115.002767
            22.  Canyelles M, Tondo M, Cedó L, Farràs M, Escolà-Gil JC,
               Blanco-Vaca F. Trimethylamine N-oxide: A  link among   32.  Dolkar P, Deyang T, Anand N,  et al. Trimethylamine-N-
               diet, gut microbiota, gene regulation of liver and intestine   oxide and cerebral stroke risk: A  review.  Neurobiol Dis.
               cholesterol homeostasis and HDL function. Int J Mol Sci.   2024;192:106423.
               2018;19(10):3228.
                                                                  doi: 10.1016/j.nbd.2024.106423
               doi: 10.3390/ijms19103228
                                                               33.  Constantino-Jonapa LA, Espinoza-Palacios Y, Escalona-
            23.  Luo J, Yang H, Song BL. Mechanisms and regulation   Montaño AR, et al. Contribution of trimethylamine N-oxide
               of cholesterol homeostasis.  Nat Rev Mol Cell Biol.   (TMAO)  to  chronic  inflammatory  and  degenerative
               2020;21(4):225-245.                                diseases. Biomedicines. 2023;11(2):431.
               doi: 10.1038/s41580-019-0190-7                     doi: 10.3390/biomedicines11020431


            Volume 3 Issue 3 (2024)                         7                                doi: 10.36922/an.3005
   40   41   42   43   44   45   46   47   48   49   50